Time to Question Long-Term Safety of Routine Scheduled Inhaled β-2-agonist Treatment for COPD

Lignende værker

• The role of combination inhaled corticosteroid/long-acting β-agonist therapy in COPD management
  af: Mapel, Douglas W, et al.
  Udgivet: (2010)
• Combining inhaled glucocorticoids and long acting β(2)-adrenoceptor agonists in asthma and COPD
  af: Knox, A J, et al.
  Udgivet: (2008)
• Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD
  af: Pavord, Ian D, et al.
  Udgivet: (2016)
• Long-term safety and efficacy of formoterol fumarate inhalation solution in patients with moderate-to-severe COPD
  af: Hanania, Nicola A, et al.
  Udgivet: (2018)
• Inhaled β-agonist does not modify sympathetic activity in patients with COPD
  af: Haarmann, Helge, et al.
  Udgivet: (2015)